Fall in human papillomavirus prevalence following a national vaccination program

Journal of Infectious Diseases

Volumn 206, Issue 11, 2012, Pages 1645-1651

  Tabrizi, Sepehr N ^a,b,c,d   Brotherton, Julia M L ^e,h   Kaldor, John M ⁱ   Skinner, S Rachel ^h   Cummins, Eleanor ^d   Liu, Bette ⁱ   Bateson, Deborah ^c   McNamee, Kathleen ^f,g   Garefalakis, Maria ^j   Garland, Suzanne M ^a,b,c,d  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Department of Microbiology ^*  (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e VICTORIAN CYTOLOGY SERVICE   (Australia)

^f Family Planning Victoria   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j Family Planning Western Australia   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LABORATORY TEST; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

ADOLESCENT; ALPHAPAPILLOMAVIRUS; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; YOUNG ADULT;

EID: 84869018940     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis590     Document Type: Article

References (26)

1. Gertig DM, Brotherton JM, Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011; 8:171-78.
2. Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011; 35:197-201.
3. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-27.
4. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199:805-14.
5. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928-43.
6. Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11:39-44.
7. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2011; 87:544-47.
8. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377:2085-92.
9. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 2004; 23:569-78.
10. World Health Organization. Report of the meeting on HPV vaccine coverage and impact monitoring. WHO/IVB/10
11. Geneva, Switzerland, 2010. http://whqlibdoc.who.int/hq/2010/WHO-IVB-10. 05-eng.pdf. Accessed 15 April 2012.
12. Brotherton JM, Kaldor JM, Garland SM. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sex Health 2010; 7:310-19.
13. Wong CA, Saraiya M, Hariri S, et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine 2011; 29:878-85.
14. Garland SM, Brotherton JM, Condon JR, et al. Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med 2011; 9:104.
15. Stevens MP, Rudland E, Garland SM, Tabrizi SN. Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche Amplicor and Linear Array HPV tests. J ClinMicrobiol 2006; 44:2428-33.
16. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J ClinMicrobiol 2000; 38:357-61.
17. Layton-Henry J, Scurry J, Planner R, et al. Cervical adenoid basal carcinoma, five cases and literature review. Int J Gynecol Cancer 1996; 6:193-99.
18. Stevens MP, Garland SM, Tabrizi SN. Validation of an automated detection platform for use with the Roche Linear Array human papillomavirus genotyping test. J ClinMicrobiol 2008; 46:3813-16.
19. Stevens MP, Garland SM, Tabrizi SN. Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods 2006; 135:124-6.
20. Tabrizi SN, Stevens M, Chen S, Rudland E, Kornegay JR, Garland SM. Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus. Am J ClinPathol 2005; 123:896-99.
21. Stevens MP, Garland SM, Tabrizi SN. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods 2008; 147:290-96.
22. Pink B. Information paper: an introduction to socio-economic indexes for areas (SEIFA) 2006. Australian Bureau of Statistics (ABS) catalogue no. 2039.0. Canberra, Australia: ABS, 2008.
23. Australian Institute of Health and Welfare (AIHW). Rural, regional and remote health: a guide to remoteness classifications. AIHW catalogue no. PHE 53 Canberra, Australia: AIHW, 2004.
24. Smith A, Agius P, Mitchell A, Barrett C, Pitts M. Secondary students and sexual health 2008. Melbourne, Australia: Australian Research Centre in Sex, Health and Society, 2009.
25. Rissel CE, Richters J, Grulich AE, de Visser RO, Smith AM. Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust N Z J Public Health 2003; 27:131-37.
26. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012; 42:44-52.